Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Deborah

Deborah Absalon, Converse, TX US

Patent application numberDescriptionPublished
20090120960System for identifying fluid pathways through a fluid carrying device - A beverage dispensing system is disclosed, typical of prior art beverage dispensing systems, in that it is designed to dispense fluids, such as syrup and/or soda and water, from a bar gun. The bar gun is connected by a multiplicity of lines to a manifold and flow control assembly. The manifold and flow control assembly, in turn, receives a number of different fluids, typically syrup, water and soda, under pressure from a number of different pressurized containers. Applicants' novel system includes schematics, typically in the form of adhesive labels, applied to the dispensing system, typically on the manifold and flow control assembly, which schematics illustrate the button arrangement on the handle, and the inlet port layout on the handle, and relate the same, using words, symbols or a combination, to indicia identified ports on the manifold and flow control assembly.05-14-2009
20090283543Flow Control and Manifold Assembly - A device for controlled delivery of pressurized fluids from a multiplicity of pressurize fluid sources having a multiplicity of pressurized fluid lines engaged therewith to a bar gun. The device comprises a flow control assembly with a multiplicity of flow channel assemblies. Each flow channel assembly has a high pressure tube receiving port adapted to receive a fluid pressure line from a high pressure fluid source. Each flow control assembly has an on/off valve and flow control structure downstream thereof. The flow control structure may be self-adjusting or mechanical control. The flow control assembly includes a housing for engaging the fluid flow channel assemblies thereon. A manifold assembly is adapted to engage the flow control assembly. The manifold assembly includes a multiplicity of connector fittings, each having an upstream and a downstream end . The upstream end is adapted to slideably receive the outlet ports of the fluid flow channel assemblies and the downstream end is designed to engage a fluid line. A multiplicity of fluid lines engage a sheath tube assembly which usually includes a sheath tube which, at a removed end, is adapted to engage a bar gun. The flow control assembly and manifold assembly include a release member for releasably engaging the tube.11-19-2009
20100187258POST-MIX DISPENSER ASSEMBLY - A beverage dispensing assembly which has one or more urns to which a manual, post-mix valve is engaged, on front walls thereof. The urn or urns do not contain fluid, rather, at least, a pair of fluid lines carrying pressurized fluid to the post-mix valve, which may be a “T” valve. The two fluid lines carry fluid from a first and a second fluid source, typically pressurized, which sources are remote from the urn or urns. If the assembly is comprised of more than one urn, it may include a base, designed to hold the urns in side-by-side alignment.07-29-2010
20110107918POST-MIX DISPENSER ASSEMBLY - A beverage dispensing assembly which has one or more urns to which a manual, post-mix valve is engaged, on front walls thereof. The urn or urns do not contain fluid, rather, at least, a pair of fluid lines carrying pressurized fluid to the post-mix valve, which may be a “T” valve. The two fluid lines carry fluid from a first and a second fluid source, typically pressurized, which sources are remote from the urn or urns. The urns have walls defining an interior volume. The interior volume is adapted to receive lines carrying a pressurized concentrate and a pressurized base fluid, such as water. The lines are adapted to be contained at least partly within the inner volume of the urn or urns of the urn assembly and engage a near end of the post-mix “T” valve where the post-mix “T” valve engages the front wall of the urn. If the assembly is comprised of more than one urn, it may include a base, designed to hold the urns in side-by-side alignment.05-12-2011

Patent applications by Deborah Absalon, Converse, TX US

Deborah Bickmann, Urbar DE

Patent application numberDescriptionPublished
20090314287PORTABLE INHALER WITH ADD-ON DEVICE WITH A CHAMBER FOR INTERMEDIATE STORAGE OF AN ATOMIZED MEDICAMENT PREPARATION - An inhaler for propellant-free atomization of a medicament preparation. The inhaler produces an aerosol at low speed. The inhaler is combined with an add-on device for intermediate storage of the aerosol produced, so as to allow easier inhalation, particularly for children.12-24-2009

Deborah Bollini, Covo IT

Patent application numberDescriptionPublished
20110009596PROCESS FOR THE PREPARATION OF N-PROTECTED-DECYLAMINOETHANAL - Compounds useful in the preparation of telavancin, for example, were prepared. These compounds include decylaminoethanal dialkyl acetals and N-protected decylaminoethanal dialkyl acetals, imidazolidine derivatives, and N-protected-decylaminoethanal.01-13-2011

Deborah Callantine, Rocklin, CA US

Patent application numberDescriptionPublished
20100027981Infant formula maker and brewer - The present invention is a warmer for heating liquids for use with powdered infant formula. In an exemplary embodiment the device comprises a water reservoir and pump, heating element, and carafe demarcated in ounces to allow the user to easily add the appropriate amount of infant formula after the water is warmed. In use, up to 64 ounces of water is placed in the water reservoir. The reservoir warms the water to the optimum temperature and fills the carafe through a water outlet. The carafe rests on a platform that is not heated so as to not bring the temperature above the optimum temperature for making formula. As further described herein, the system ensures a smooth and silky mixed formula of the proper concentrations.02-04-2010

Deborah Defeo-Jones, Lansdale, PA US

Patent application numberDescriptionPublished
20100041666Use of N-Phenyl-2-pyrimidineamine Derivativea Against Mast Cell-based Diseases Like Allergic Disorders - Use of the N-phenyl-2-pyrimidine-amine derivatives of formula I,02-18-2010

Deborah Deryckere, Boulder, CO US

Patent application numberDescriptionPublished
20090131367Combinations of HDAC Inhibitors and Proteasome Inhibitors - Provided herein are pharmaceutical agents, pharmaceutical compositions, methods of treatment, treatment regimens and kits for the treatment of cancer.05-21-2009
20120064009METHODS OF LEUKEMIA CELL DETECTION - Methods are provided for, inter alia, determining the presence of leukemia cells in a subject, determining the change or potential change in the number of leukemia cells in the subject with time, determining whether a tissue in a subject contains a plurality of leukemia cells or a plurality progenitor leukemia cells, and determining whether a leukemia therapy administered to a subject is capable of decreasing the number of leukemia cells in a tissue of the subject.03-15-2012

Deborah De Ryckere, Boulder, CO US

Patent application numberDescriptionPublished
20110053991Treatment of Histone Deacetylase Mediated Disorders - Provided herein are pharmaceutical agents, pharmaceutical compositions, methods of treatment, treatment regimens and kits for the treatment of histone deacetylase mediated disorders.03-03-2011

Deborah Dihel, Richland, WA US

Patent application numberDescriptionPublished
20100015284SHELF STABLE FRIED PRODUCT AND PROCESS FOR CREATING THE SAME - A shelf stable fried product and a process for creating a shelf stable fried product is disclosed. Aspects include a process for managing fat migration, moisture migration, and cell degrading of a food product during frying. Aspects further include a resulting shelf stable food product that includes a crispy and/or crunchy texture and a desirable fat distribution.01-21-2010
20100015297SHELF STABLE FRIED PRODUCT AND PROCESS FOR CREATING THE SAME - A shelf stable fried product and a process for creating a shelf stable fried product is disclosed. Aspects include a process for managing fat migration, moisture migration, and cell degrading of a food product during frying. Aspects further include a resulting shelf stable food product that includes a crispy and/or crunchy texture and a desirable fat distribution.01-21-2010
20100015298SHELF STABLE FRIED PRODUCT AND PROCESS FOR CREATING THE SAME - A shelf stable fried product and a process for creating a shelf stable fried product is disclosed. Aspects include a process for managing fat migration, moisture migration, and cell degrading of a food product during frying. Aspects further include a resulting shelf stable food product that includes a crispy and/or crunchy texture and a desirable fat distribution.01-21-2010
20100316777METHOD AND APPARATUS FOR SMOKING FOOD PRODUCTS - A method and apparatus for smoking food products includes a method or apparatus configured to provide a pH level of a smoked food product. The determination of the pH level of the smoked product provides an objective measure of the amount of smoke received by the food product, as well as an indication of the agreeability of the flavor of the food product. Based on the determination of the pH level, the method and apparatus can be adjusted to provide a more consistent, high quality smoked food product.12-16-2010

Deborah Dunn-Walters, London GB

Patent application numberDescriptionPublished
20100266493AGONIST ANTIBODIES AGAINST TSHR - The invention provides antibodies that bind the thyroid stimulating hormone receptor (TSHR), especially in humans, and their uses in diagnostic and therapeutic roles. The invention also provides hybridomas for producing such antibodies.10-21-2010

Deborah Forray, San Diego, CA US

Patent application numberDescriptionPublished
20090275171METHODS FOR ASSEMBLING THIN SEMICONDUCTOR DIE - The invention is based on the discovery that certain self-filleting die attach adhesives are useful in semiconductor die assemblies containing thin die. As used herein, the term “self-filleting” refers to any adhesive that when dispensed and then subjected to suitable cure conditions, will flow and fill up the area between two die or between a die and a substrate while not forming a bulky fillet that can overflow onto the top of the die. In addition, the invention is useful for tight tolerance semiconductor die assemblies, since the fillet from the die-attach adhesives employed in the methods of the invention does not cover bond fingers, thereby causing wire bond yield loss.11-05-2009

Deborah Garcia, Freemont, CA US

Patent application numberDescriptionPublished
20110040455MOTOR VEHICLE - The present invention relates to a motor vehicle having a steering wheel, the motor vehicle including a first display, integrated into the steering wheel, for the variable representation of information; a first touchscreen, situated over the first display, for the input of commands; a second display, integrated into the steering wheel and separated spatially from the first display, for the variable representation of information; and a second touchscreen, situated over the second display, for the input of commands.02-17-2011

Deborah Gereaghty, Delanco, NJ US

Patent application numberDescriptionPublished
20100051553METHOD FOR REMOVING MERCURY FROM WASTEWATER AND OTHER LIQUID STREAMS - A method for reducing the amount of Mercury in a liquid stream, such as an aqueous wastewater or process water stream or a non-aqueous liquid hydrocarbonaceous stream is disclosed wherein the liquid stream is contacted with an effective amount of a Hg-complexing agent, the mercury contaminants in the liquid stream form insoluble complexes with the Hg-complexing agent, then the insoluble complexes are removed from the liquid stream via microfiltration or ultrafiltration techniques including the use of submerged hollow fiber ultrafilters or the like.03-04-2010

Deborah Grill, Oxford GB

Patent application numberDescriptionPublished
20100292307Construct - A promoter for high level and sustained expression is provided which can be used for gene expression of chosen sequences in general. In particular, a nucleic acid construct comprising a hCEF1 promoter operably linked to a sequence for expression is provided, where the hCEF1 promoter comprises: (i) a human CMV enhancer operably linked to a human EF1 a promoter; (ii) a functional fragment of (i); or (ii) a functional variant of (i) or (ii).11-18-2010

Deborah Herb-Weinert, Big Sandy, TN US

Patent application numberDescriptionPublished
20100072233Fringe maker - A fringe maker for winding yarns to make a fringe. The fringe maker includes an elongated base having a pair of spaced crank and idler support member recesses interconnected by a longitudinal winding rod recess, a gripping slot, and a ruler recess. A pair of crank and idler support members are pivotally connected to the base within respective of the crank and idler support member recesses. Each has an upright operating position stopped against the base and a horizontal storage position disposed within the support member recesses that each define a storage area thereunder. A pair of crank and idler winding arms each have a central area rotatably connectable to respective of the support members while in the operating positions to rotate about a horizontal axis. A pair of elongated winding rods are disposable in a plurality of spaced relationships equidistant from and at opposite sides of the axis to interconnect the winding arms and form a removable winding unit. A hand crank is used for hand-driving the crank winding arm. A middle winding arm has a pair of end slots and two pluralities of side slots that closely receive the winding rods in the spaced relationships that snap-fits to the winding rods intermediate the winding arms. A bendable ruler closely fits within the ruler recess for storage.03-25-2010

Deborah Johnson-Jackson, Canby, CA US

Patent application numberDescriptionPublished
20090263355DEAMIDATED INTERFERON-BETA - Interferon-β protein analogs in which the asparagine at position 25, numbered in accordance with native interferon-β, is deamidated exhibit a biological activity of native human interferon-β at an increased level and do not require HA for protein stabilization. The deamidated product is suitable for large scale manufacturing for incorporation in HA-containing or HA-free therapeutics for treatment of diseases including multiple sclerosis. An endoproteinase-C peptide map technique that produces a fingerprint profile for proteins using an enzymatic digest followed by RP-HPLC is also useful in quality control as an ID and/or quantitative test for the deamidated products.10-22-2009
20090311216RECOMBINANT INTERFERON-BETA WITH ENHANCED BIOLOGICAL ACTIVITY - Human interferon-β protein analogs in which the asparagine at position 25, numbered in accordance with native human interferon-β, is recombinantly replaced with an aspartate residue exhibit a biological activity of human interferon-β (e.g. IFN-β 1b) at an increased level relative to IFN-β 1b. These analogs are obtained by introducing a gene coding for Asp25 IFN-β into a cell and expressing the recombinant protein. The resulting IFN-β protein analog is suitable for large scale manufacturing for incorporation in HA-containing or HA-free therapeutics for treatment of diseases including multiple sclerosis. A reduced Lys endoproteinase-C peptide map technique that produces a fingerprint profile for proteins using an enzymatic digest followed by RP-HPLC is also useful in quality control as an ID test for the IFN-β protein analog products.12-17-2009

Deborah Jones, St Martin De Londres FR

Patent application numberDescriptionPublished
20100151351 MONOMERS AND POLYMERS CARRYING IMIDAZOLE AND BENZIMIDAZOLE GROUPINGS, AND PROTON EXCHANGE MEMBRANE CONTAINING THE SAME FOR THE PRODUCTION OF A FUEL CELL - The invention relates to a monomer (06-17-2010

Patent applications by Deborah Jones, St Martin De Londres FR

Deborah Karie, Lawrenceburg, KY US

Patent application numberDescriptionPublished
20090183327Fingernail cleaning brush - A nail cleaning brush is designed to easily clean under a person's fingernail with or without an anti-bacterial solution. The shape of the brush and the handle are designed to facilitate ease-of-use and effectiveness. The handle can include a hollow portion to hold a fluid that can be dispensed through the tip of the brush. The solution can be detergent, soap, anti-bacterial solution and the like.07-23-2009

Deborah Kennison, Wayne, NJ US

Patent application numberDescriptionPublished
20090238905INFLAMMATION REDUCING ACTION OF SYNERGISTIC MIXTURES OF BISABOLOL AND GINGER EXTRACTS - A formulation for treating or eliminating irritation and/or inflammation-reducing effect on endodermal tissue of the respiratory tract, the gastrointestinal tract, or both is disclosed. The formulation can include bisabolol or an extract containing bisabolol and actives found in ginger or extracted from ginger. The ratio of bisabolol and actives from ginger is adjusted such that the irritation and inflammation-reducing action of the bisabolol constituents and ginger constituents is increased synergistically.09-24-2009
20090291121CAPSULE AND COATED CAPSULES AS A DELIVERY SYSTEM FOR DIETARY SUPPLEMENTS AND THERAPEUTIC MATERIALS - A coated spherical capsule that comprises a seamless capsule and an edible coating is disclosed. The seamless capsule includes a seamless solid shell surrounding a mononuclear liquid or viscous core and the edible coating surrounding the seamless capsule. The edible coating can include at least one dietary supplement and at least one sugar or sugar alcohol. The liquid or viscous core can include 1-100% of a flavoring, based on total weight of the liquid or viscous core. The edible coating can include an effective amount of the at least one dietary supplement based on the weight of the edible coating. Also disclosed is a method of administering an effective amount of a dietary supplement. The method includes providing a plurality of coated spherical capsule and ingesting at least one coated spherical capsule for two or more days in order to deliver an effective amount of a dietary supplement.11-26-2009
20100151055Aroma Composition to Reduce or Suppress Undesirable Bitter and Astringent Taste Impressions of Sweeteners - The invention concerns an aroma composition to reduce or suppress a bitter or astringent impression in the oral cavity, comprising (i) one or more sweeteners and (ii) one or more specific bitter-masking aroma substances and/or flavourings and optionally (iii) one or more sweetness intensifying aroma substances and/or sweeteners and optionally (iv) one or more inactive substances or carriers. The invention also concerns a preparation, containing such an aroma composition, the use of an aroma composition for reducing or eliminating a bitter and astringent effect of an artificial sweetener and a corresponding method for reducing or eliminating the bitter and astringent effect of a sweetener.06-17-2010
20110158919AROMA COMPOSITION COMPRISING O-COUMARIC ACID TO REDUCE OR SUPPRESS UNDESIRABLE TASTE IMPRESSIONS OF SWEETENERS - The invention concerns an aroma composition to reduce or suppress undesirable taste impressions, in particular a bitter, astringent and/or sweetener-like taste and/or long-lasting aftertaste of a sweetener, in the oral cavity, comprising (i) one or more sweeteners and (ii) ortho-coumaric acid (OCA) and optionally (iii) one or more specific bitter-masking aroma substances and/or flavourings and optionally (iv) one or more sweetness intensifying aroma substances and/or sweeteners and optionally (v) one or more inactive substances or carriers. The invention also concerns a preparation, containing such an aroma composition. The invention also relates to the use of ortho-coumaric acid or of certrain aroma compositions comprising ortho-coumaric acid for reducing or eliminating undesirable taste effects, in particular a bitter, astringent and/or sweetener-like taste and/or long-lasting aftertaste of a sweetener, and corresponding methods for reducing or eliminating the undesirable taste impression, in particular a bitter, astringent and/or sweetener-like taste and/or long-lasting aftertaste of a sweetener.06-30-2011

Patent applications by Deborah Kennison, Wayne, NJ US

Deborah Knutzon, Granite Bay, CA US

Patent application numberDescriptionPublished
20100310710METHODS AND COMPOSITIONS FOR SYNTHESIS OF LONG CHAIN POLYUNSATURATED FATTY ACIDS - The present invention relates to fatty acid desaturases able to catalyze the conversion of oleic acid linoleic acid, linoleic acid to γ-linolenic acid, or of alpha-linolenic acid to stearidonic acid. Nucleic acid sequences encoding desaturases, nucleic acid sequences which hybridize thereto, DNA constructs comprising a desaturase gene, and recombinant host microorganism or animal expressing increased levels of a desaturase are described. Methods for desaturating a fatty acid and for producing a desaturated fatty acid by expressing increased levels of a desaturase are disclosed. Fatty acids, and oils containing them, which have been desaturated by a desaturase produced by recombinant host microorganisms or animals are provided. Pharmaceutical compositions, infant formulas or dietary supplements containing fatty acids which have been desaturated by a desaturase produced by a recombinant host microorganism or animal also are described.12-09-2010
20110256260METHODS AND COMPOSITIONS FOR SYNTHESIS OF LONG CHAIN POLYUNSATURATD FATTY ACIDS - The present invention relates to fatty acid desaturases able to catalyze the conversion of oleic acid linoleic acid, linoleic acid to γ-linolenic acid, or of alpha-linolenic acid to stearidonic acid. Nucleic acid sequences encoding desaturases, nucleic acid sequences which hybridize thereto, DNA constructs comprising a desaturase gene, and recombinant host microorganism or animal expressing increased levels of a desaturase are described. Methods for desaturating a fatty acid and for producing a desaturated fatty acid by expressing increased levels of a desaturase are disclosed. Fatty acids, and oils containing them, which have been desaturated by a desaturase produced by recombinant host microorganisms or animals are provided. Pharmaceutical compositions, infant formulas or dietary supplements containing fatty acids which have been desaturated by a desaturase produced by a recombinant host microorganism or animal also are described. 10-20-2011

Deborah Ladenheim, Dexter, MI US

Patent application numberDescriptionPublished
20110268731METHODS OF TREATING AUTOIMMUNE DISORDERS AND/OR INFLAMMATORY DISORDERS - The present invention relates to dendrimer compositions configured for treating inflammatory disorders and autoimmune disorders, and related methods of synthesis. Specifically, the present invention relates to methods for treating rheumatoid arthritis with PAMAM dendrimers having functional ligands configured for treating rheumatoid arthritis (e.g., therapeutic agents, pro-drugs, targeting agents, trigger agents, imaging agents) (e.g., methotrexate).11-03-2011

Deborah Lyzenga, Long Valley, NJ US

Patent application numberDescriptionPublished
20100018974PACKAGE INTEGRITY INDICATING CLOSURE - A resealable closure for a container in which package integrity is indicated by a structure which connects the closure to a remaining portion of the container which must be broken in order to gain access to the contents of the container for a first time. The package integrity feature, in one form, includes a structure associated with the closure, wherein upon opening the closure for a first time, the structure stretches, increasing a length of the structure until the structure eventually breaks, leaving one or both residual ends of the broken structure rippled or curved upward from the remainder of the container. In one alternative form, the structure is associated with a pull tab of the sealing panel, which comprises the closure, whereby either the structure must be broken first, prior to pulling back the sealing panel, or while pulling back the sealing panel for a first time, the structure breaks, prior to gaining access to the contents therein. Advantageously, the package integrity feature is integrally formed with the closure and a remaining portion of the container. Integrity of the package is indicated by visually observing an intact breakable structure.01-28-2010

Deborah Magglo, Montville, NJ US

Patent application numberDescriptionPublished
20090193562Finger puppet novelty hand garment - The invention is an article of manufacture comprising a glove or mitten having a thumb region and a forefinger region and a character disposed across the middle finger and thumb regions. The character is placed such that the top of the character's face and mouth is across the middle finger region, and the bottom of the mouth is across the thumb region. The mouth is therefore open when the thumb region and middle finger region are not touching each other, and is closed when the thumb region and middle finger region are touching.08-06-2009

Deborah Makita, Lawrenceville, GA US

Patent application numberDescriptionPublished
20100084757CONDUCTIVE COMPOSITIONS AND METHODS OF USING THEM - A conductive composition includes a mono-acid hybrid that includes an unprotected, single reactive group. The mono-acid hybrid may include substantially non-reactive groups elsewhere such that the mono-acid hybrid is functional as a chain terminator. Methods and devices using the compositions are also disclosed.04-08-2010

Deborah Marrone, Maasmechelen BE

Patent application numberDescriptionPublished
20090211463STORAGE BIN, IN PARTICULAR FOR STORING FOODSTUFFS, MORE PARTICULARLY FOR STORING BREAD - The invention relates to a storage bin, in particular a bin of storing foodstuffs, more particularly a bin for storing bread, comprising a box having an opening as well as a lid which is suspended from the box and can be moved between an open and a closed position for opening and closing the opening, respectively, characterized by pressing means for forcing the lid into the open position, and a closure which can be brought into an operative position for keeping the lid in the closed position and which can be brought into an inoperative position for moving the lid into the open position under the effect of the pressing means.08-27-2009

Deborah Meshulam, Brookline, MA US

Patent application numberDescriptionPublished
20110166319PROCESS FOR PREPARING PURIFIED DRUG CONJUGATES - The invention provides processes for preparing a cell-binding agent chemically coupled to a drug. A first process comprises covalently attaching a linker to a cell-binding agent, an optional purification step, conjugating a drug to the cell-binding agent, a subsequent purification step, and optional holding steps. A second process comprises covalently attaching a linker to a cell-binding agent, a purification step, conjugating a drug to the cell-binding agent, a subsequent purification step, holding steps, and optionally a tangential flow filtration (TFF) step.07-07-2011

Deborah Molrine, Newton, MA US

Patent application numberDescriptionPublished
20100233181ANTIBODIES AGAINST CLOSTRIDIUM DIFFICILE TOXINS AND USES THEREOF - Antibodies that specifically bind to toxins of 09-16-2010
20100233182Antibodies against Clostridium difficile toxins and uses thereof - Antibodies that specifically bind to toxins of 09-16-2010

Deborah Nguyen, San Dieago, CA US

Patent application numberDescriptionPublished
20090252757METHODS AND COMPOSITIONS FOR INHIBITING HIV INFECTION - This invention provides novel HIV-interacting host factors. The invention also provides methods of using the HIV-interacting host factors to screen for compounds that inhibit HIV infection. The methods comprise first screening test compounds for modulators of an HIV interacting host factor disclosed herein, and then further screening the identified modulating compounds for ability to inhibit HIV infection. The invention further provides methods and pharmaceutical compositions for treating diseases and conditions associated with HIV infection.10-08-2009

Deborah Nusskern, Forest Park, IL US

Patent application numberDescriptionPublished
20080213791Materials and methods for assaying for methylation of CpG islands associated with genes in the evaluation of cancer - Provided are methods, reagents, and kits for evaluating cancer, such as prostate cancer, in a subject. Disclosed methods of evaluating cancer include methods of diagnosing cancer, methods of prognosticating cancer and methods of assessing the efficacy of cancer treatment. The methods include assaying a biological sample for methylation of a CpG island associated with specified genes. Provided reagents and kits include primers suitable for amplifying at least a portion of a target CpG islands associated with specified genes.09-04-2008
20110097728MATERIALS AND METHOD FOR ASSAYING FOR METHYLATION OF CpG ISLANDS ASSOCIATED WITH GENES IN THE EVALUATION OF CANCER - Provided are methods, reagents, and kits for evaluating cancer, such as prostate cancer, in a subject. Disclosed methods of evaluating cancer include methods of diagnosing cancer, methods of prognosticating cancer and methods of assessing the efficacy of cancer treatment. The methods include assaying a biological sample for methylation of a CpG island associated with specified genes. Provided reagents and kits include primers suitable for amplifying at least a portion of a target CpG islands associated with specified genes.04-28-2011

Deborah Ockert, Hamburg DE

Patent application numberDescriptionPublished
20100120757PYRAZOLONE DERIVATIVES AS PDE4 INHIBITORS - The compounds of a certain formula 1,05-13-2010

Deborah Panna, Throop, PA US

Patent application numberDescriptionPublished
20100242146Nape pad / chin strap retention assemblies for ballistic helmets - There is provided a protective helmet assembly that includes a shell, a suspension band, and an adjustable headband and a crown pad. The shell is constructed from at least PARA-ARAMID to provide ballistic protection. The adjustable headband and the crown pad each have a plurality of screw less connectors for directly securing the adjustable headband and the crown pad to the suspension band without screws. A nape pad subassembly is adjustably coupled to the shell via rear fasteners. A chin strap subassembly is adjustably coupled between the front fasteners and the nape pad subassembly by a multi-connection point coupling.09-30-2010

Deborah Parenza, Des Moines, IA US

Patent application numberDescriptionPublished
20100294754Ergonomic Commercial Microwave Oven - A microwave oven cabinet is ergonomic designed to provide for both stacking and jigsaw-type back-to-back interlining of multiple units of the microwave ovens. In particular, the cabinet configuration advantageously establishes a reduced footprint, ergonomically designed microwave oven which can be effectively employed in various fields, including fast food chains wherein multiple such ovens may need to be functionally positioned in a limited area, while still being easily accessible.11-25-2010

Deborah Pico, Fort Lee, NJ US

Patent application numberDescriptionPublished
20100276430Hot/cold container and lid - A hot/cold container and lid is described. The container comprising: a bottom plate; a plurality of inner walls extending substantially perpendicular to said bottom plate, forming a hollow, therebetween; a plurality of outer walls extending substantially perpendicular to the bottom plate and substantially parallel to, and spaced from, a corresponding one of the inner walls, the spacing forming a compartment between the inner and outer walls, wherein corresponding ones of the inner and outer walls are attached at selected points between the inner and outer walls to provide at least one substantially uninterrupted compartment, therebetween. The Lid may be of a transparent, semi-transparent or opaque material and may be of a material that operates as a cutting board.11-04-2010

Deborah Rauner, Sandy Hook, CT US

Patent application numberDescriptionPublished
20100160371INHIBITION OF P38 KINASE ACTIVITY BY ARYL UREAS - This invention relates to the use of a group of aryl ureas in treating cytokine mediated diseases other than cancer and proteolytic enzyme mediated diseases other than cancer, and pharmaceutical compositions for use in such therapy.06-24-2010

Deborah Schechtman, Ipanema BR

Patent application numberDescriptionPublished
20090155236Peptide sequence for modulation of delta protein kinase c - A peptide identified from the annexin V protein sequence and having the ability to modulate the activity of delta protein kinase C (PKC) is described. The peptide and variants thereof bind to delta PKC and are effective to regulate delta PKC mediated cellular responses. In particular the annexin V peptide is able to inhibit protein-protein interaction with delta PKC, blocking intracellular translocation of delta PKC. Inhibition of delta PKC translocation confers protection to tissue at risk of exposure to ischemia or hypoxia or to reperfusion injury.06-18-2009

Deborah Schenberger, Portland, OR US

Patent application numberDescriptionPublished
20120136229STRAIN MONITORING SYSTEM AND APPARATUS - A system for monitoring strain as an indicator of biological conditions, such as spinal fusion, glucose levels, spinal loading, and heart rate. The system includes an inter-digitated capacitor sensor, and RF transmitter, and an associated antenna, all of which are microminiature or microscopic in size and can be implanted in a biological host such as a human or animal. An inductively coupled power supply is also employed to avoid the need for implantation of chemical batteries. Power is provided to the sensor and transmitter, and data is transmitted from the sensor, when an external receiving device, such as a handheld RF ID type receiver, is placed proximate the location of the implanted sensor, transmitter and inductively coupled power supply. The implanted sensor, transmitter and inductively coupled power supply can be left in place permanently or removed when desired.05-31-2012
20120136278STRAIN MONITORING SYSTEM AND APPARATUS - A system for monitoring strain as an indicator of biological conditions, such as spinal fusion, glucose levels, spinal loading, and heart rate. The system includes an inter-digitated capacitor sensor, and RF transmitter, and an associated antenna, all of which are microminiature or microscopic in size and can be implanted in a biological host such as a human or animal. An inductively coupled power supply is also employed to avoid the need for implantation of chemical batteries. Power is provided to the sensor and transmitter, and data is transmitted from the sensor, when an external receiving device, such as a handheld RF ID type receiver, is placed proximate the location of the implanted sensor, transmitter and inductively coupled power supply. The implanted sensor, transmitter and inductively coupled power supply can be left in place permanently or removed when desired.05-31-2012

Deborah Schunder, West Hartford, CT US

Patent application numberDescriptionPublished
20100131423SYSTEM AND METHOD FOR ADMINISTERING A DESTINATION FUND HAVING AN ASSOCIATED GUARANTEE - A system is provided for administering a destination fund having a guarantee wrapper. The guarantee provides an income stream for life to one or more investors. The destination fund has a selected mix of equities and fixed income investments to provide for enhanced returns throughout retirement for the investor. The destination fund additionally provides income stream flexibility throughout the lifetime of the investor. Administration of a destination fund having a guarantee wrapper may include initiating a guarantee payment process if a value of the destination fund falls below a threshold.05-27-2010

Deborah Sklenarik, Friendswood, TX US

Patent application numberDescriptionPublished
20090094752Support Pillow for Breastfeeding - Disclosed is a substantially c-shaped pillow that offers support to a woman's breast, particularly during breastfeeding. The breast pillow wraps around the breast offering support to the entire breast and assisting in proper placement of the breast during breastfeeding, freeing the woman from having to use her hand to hold her breast in place.04-16-2009

Deborah Strootman, Tucson, AZ US

Patent application numberDescriptionPublished
20110092599Use of Treprostinil to treat neuropathic diabetic foot ulcers - The present invention describes novel methods for using 9-deoxy-2′,9-α-methano-3-oxa-4,5,6-trinor-3,7-(1′,3′-interphenylene)-13,14-dihydro-prostaglandin F04-21-2011

Deborah Tacoma, Zeeland, MI US

Patent application numberDescriptionPublished
20090159487LONG-HANDLED DEVICE FOR PERSONAL HYGIENE AND DAILY LIVING - A long-handled personal holder device for personal cleaning, hygiene, and daily living, and is made of resilient material with extendable finger-like grips. The grips are configured to surely grip a tool, but also to release (e.g., so that a user does not have to soil their hands). The curved handle allows proper reach, and is designed for easy break-down, rinsing and cleaning, and for placement in a compact carry bag. The grips can grip a larger personal hygiene flushable wipe, a smaller flushable pad, a sponge for shower use, and/or a an ointment pad; and are also able to hold more rigidly-handled personal tools, such as a toothbrush, shaver, makeup applicator, pencil, pen, brush, and similar items.06-25-2009

Deborah Teboul, Vitrolles FR

Patent application numberDescriptionPublished
20110163167CONTACTLESS CARD WITH SECURITY LOGO - The invention relates to a contactless smart card that comprises a card body and an electronic module provided with an electronic chip connected to the terminals of an antenna, the electronic module being arranged in a recess formed in the card body, wherein the exposed surface of the electronic module comprises at least one graphic security element capable of protecting said electronic module and the contactless card against attempts at fraud.07-07-2011

Deborah Teoli, Torreglia IT

Patent application numberDescriptionPublished
20100197032NANOASSEMBLED COMPLEXES OF NUCLEIC ACIDS, AVIDIN AND POLYMERS, USE AND PREPARATION THEREOF - The present invention discloses new nanoassembled complexes consisting of a central nucleus formed by a high-affinity interaction from nucleic acids and avidin, wherein said nucleus is stabilized in aqueous solutions, even saline, and protected from further unspecific unwanted interactions by means of suitable polymeric agents capable to mask totally or partially the nucleus itself. The nanocomplexes obtained have been shown to be stable in aqueous solutions and to have nanoparticle features. In addition, the nano-complexes have shown characteristics useful for use in biotechnological field and in nanomedicine.08-05-2010

Deborah Triboullard, Roscoff FR

Patent application numberDescriptionPublished
20090306430Use of Guanabenz and Its Derivatives for Making Drugs for Treating Cystic Fibrosis and Diseases Related to a Protein Addressing Deficiency in the Cells - The invention concerns the use of guanabenz and its derivatives for making drugs for treating cystic fibrosis and diseases related to a protein addressing deficiency in the cells, said derivatives corresponding to formula (I), wherein: R═H or C1 and the phenyl group comprises two substituents, or a pharmaceutically acceptable salt of said derivatives.12-10-2009

Deborah Unser, Lindsay, CA US

Patent application numberDescriptionPublished
20090056115Heat Indicating Electrical Wall Fixture Gripping Testing and Installation Device - A method and apparatus for the safe and easy installation, inspection, and maintenance of wall-mounted electrical outlets and switches utilizing a multi-functional tool. Two different but similar tools are provided, each in the form of an insulated handle that may be detachably engaged with either a wall socket or a wall switch. The wall socket device includes one or more prongs for temporary engagement with slots in the socket fixture, and may include testing circuitry. The wall switch device is temporarily attached to a switch fixture using one or more magnets. Both tools may also include built-in electrical wire measuring, stripping and bending structures, as well as electrical power sensors and means for indicating the temperature of the outlet or switch.03-05-2009

Patent applications by Deborah Unser, Lindsay, CA US

Deborah Volkots, San Diego, CA US

Patent application numberDescriptionPublished
20100081673HETEROARYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS - Described herein are compounds that are antagonists of PGD04-01-2010
20110039852N,N-DISUBSTITUTED AMINOALKYLBIPHENYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS - Described herein are compounds that are antagonists of PGD02-17-2011
20110082164POLYCYCLIC COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS - Described herein are compounds that are antagonists of lysophosphatidic receptor(s). Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such antagonists, alone and in combination with other compounds, for treating LPA-dependent or LPA-mediated conditions or diseases.04-07-2011
20110082181Compounds as Lysophosphatidic Acid Receptor Antagonists - Described herein are compounds that are antagonists of lysophosphatidic receptor(s). Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such antagonists, alone and in combination with other compounds, for treating LPA-dependent or LPA-mediated conditions or diseases.04-07-2011

Deborah Volkots, La Jolla, CA US

Patent application numberDescriptionPublished
20110312974HETEROARYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS - Described herein are compounds that are antagonists of PGD12-22-2011
20110319445HETEROARYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS - Described herein are heteroaryl compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions and medicaments that include the heteroaryl compounds described. Also described herein are methods of using such antagonists of PGD2 receptors, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other PGD2-dependent or PGD2-mediated conditions or diseases.12-29-2011
20120058123N,N-DISUBSTITUTED AMINOALKYLBIPHENYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS - Described herein are compounds that are antagonists of PGD03-08-2012

Deborah Walker, Los Angeles, CA US

Patent application numberDescriptionPublished
20090265248 Virtual Concierge for Shipping Services - A virtual concierge for shipping services is disclosed. One aspect of certain embodiments includes providing an automated computer-implemented self-service front-end shipping system to business concerns for self-service access by the customers of the respective business concern for shipping the customer's packages.10-22-2009

Deborah Winetzky, Foster City, CA US

Patent application numberDescriptionPublished
20100168383Skin or Hair Binding Peptides - The invention is directed to peptides. Specifically, the invention is directed to peptides which bind skin and do not bind hair. Alternatively, the invention is drawn to peptides which bind hair and do not bind skin.07-01-2010

Deborah Yaver, Davis, CA US

Patent application numberDescriptionPublished
20100034797Lipase Variants for Pharmaceutical Use - The pharmaceutical use of lipases related to the 02-11-2010

Deborah Yellowaga, Chandler, AZ US

Patent application numberDescriptionPublished
20090253268POST-CONTACT OPENING ETCHANTS FOR POST-CONTACT ETCH CLEANS AND METHODS FOR FABRICATING THE SAME - Post-contact opening etchants for post-etch cleans and methods for fabricating such etchants are provided. In an exemplary embodiment, a post-contact opening etchant comprises anhydrous hydrogen fluoride and a fluoride-dissociation modulating agent. In another embodiment, a method for fabricating a post-contact opening etchant comprises providing anhydrous hydrogen fluoride, combining the anhydrous hydrogen fluoride and a fluoride-dissociation modulating agent, and mixing the anhydrous hydrogen fluoride and the fluoride-dissociation modulating agent to form a homogeneous mixture.10-08-2009

Deborah Yurgelun-Todd, Salt Lake City, UT US

Patent application numberDescriptionPublished
20100041620METHODS FOR IMPROVING FRONTAL BRAIN BIOENERGETIC METABOLISM - The invention provides methods and compositions for augmenting bioenergetic metabolism in the frontal brain involving administration of a cytidine-containing or uridine-containing compound to a human.02-18-2010
20100041621METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE PERFORMANCE - The invention provides methods and compositions for improving cognitive performance involving administration of a cytidine-containing or uridine-containing compound to a neuropsychologically healthy human.02-18-2010